Prevention of Neonatal Abstinence Syndrome

Trial Profile

Prevention of Neonatal Abstinence Syndrome

Phase of Trial: Phase I/II

Latest Information Update: 29 May 2013

At a glance

  • Drugs Ondansetron (Primary)
  • Indications Nausea; Neonatal-disorders
  • Focus Pharmacokinetics
  • Acronyms Zofran-PK
  • Most Recent Events

    • 01 May 2013 Status changed from recruiting to completed as reported by
    • 11 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top